Genitourinary Cancer News

The economic cost of cancer worldwide from 2020 to 2050 will be $25.2 trillion in international dollars, according to results of a decision analytical modeling study published in JAMA Oncology.

SAN FRANCISCO — Nivolumab plus cabozantinib extended OS and PFS compared with sunitinib as first-line treatment for patients with advanced renal cell carcinoma, according to updated results of the randomized phase 3 CheckMate 9ER trial.

Healio | HemOnc Today is excited to announce a new physician leadership structure, which features seven Associate Medical Editors from various subspecialty areas within oncology and hematology.

Improvement in the American Heart Association’s Life’s Simple 7 CV health score was associated with lower risk for cancer and CVD during nearly 25 years of follow-up, researchers reported.

Researchers observed significant racial disparities in all-cause and CVD mortality among adults with cancer, with wider gaps found among patients younger than 55 years, according to a study published in JACC: CardioOncology.

SAN FRANCISCO — The addition of atezolizumab to platinum-based chemotherapy failed to significantly improve survival for patients with metastatic urothelial carcinoma, according to a final analysis of the randomized phase 3 IMvigor130 trial.

Using pre-transplant immunosuppression to treat kidney transplant recipients with glomerulonephritis correlates with an increased risk for developing malignancy after transplant, according to a retrospective study.

SAN FRANCISCO — Adjuvant nivolumab improved outcomes compared with placebo for patients with high-risk muscle-invasive urothelial carcinoma, according to study results.

SAN FRANCISCO — Several potential genetic biomarkers may predict how patients with advanced urothelial carcinoma will respond to enfortumab vedotin, according to retrospective study results.

SAN FRANCISCO — Neoadjuvant chemo-immunotherapy led to significant downstaging prior to definitive surgery for patients with muscle-invasive urothelial cancer, according to data presented at ASCO Genitourinary Cancers Symposium.